Virax Biolabs extends distribution agreement to market Mpox detection kits

seekingalpha09-16

Virax Biolabs (NASDAQ:VRAX) said it has entered into an extension of its already existing exclusive distribution agreement with Cosmos Health (COSM) to commercialize Mpox Virus Real-Time PCR Detection...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment